A RARE PRESENTATION OF SYSTEMIC-ONSET POLYARTHRITIC JUVENILE IDIOPATHIC ARTHRITIS WITH SEVERE ITCHING WITHOUT RASH

Main Article Content

Dr Jatin Haritash
Dr Jatin Prajapati

Keywords

Juvenile Idiopathic Arthritis; Systemic-Onset JIA; Autoimmunity; Antinuclear Antibody; Methylprednisolone pulse therapy.

Abstract

Systemic-onset juvenile idiopathic arthritis (SJIA) is a distinct subtype of juvenile idiopathic arthritis characterized by quotidian fever, arthritis, lymphadenopathy, hepatosplenomegaly, and an evanescent rash. Dermatologic manifestations are typical in systemic disease, commonly presenting as a salmon-pink rash. However, isolated severe pruritus without rash is extremely uncommon and may create diagnostic uncertainty. We report a 5-year-old male with a 2-month history of intermittent high-grade fever, progressively worsening polyarthritis, and severe pruritus without visible skin rash. Examination revealed generalized lymphadenopathy, multiple polyarticular joint swellings, and scratch marks without erythema. Laboratory evaluation showed anemia, neutrophilic leukocytosis, thrombocytosis, markedly elevated C-reactive protein, and positive antinuclear antibody with nuclear and speckled pattern. Radiography revealed periarticular osteopenia without erosions. The child was treated with NSAIDs, antibiotics, and subsequently high-dose pulse methylprednisolone following ANA positivity, resulting in dramatic clinical improvement. He was discharged on weekly methotrexate with folic acid supplementation. This case highlights an atypical presentation of SJIA where severe itching without rash may obscure the diagnosis. Early recognition and initiation of immunosuppressive therapy can prevent long-term sequelae.

Abstract 60 | PDF Downloads 17

References

1. Long AM, Marston B. Juvenile idiopathic arthritis. Pediatrics in Review. 2023 Oct 1;44(10):565-77. https://publications.aap.org/pediatricsinreview/article/44/10/565/194012/ Juvenile-Idiopathic-Arthritis
2. Petty RE, Southwood TR, Manners P, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. The Journal of rheumatology. 2004 Feb;31(2):390-2.
3. Gurion R, Lehman TJ, Moorthy LN. Systemic arthritis in children: a review of clinical presentation and treatment. International journal of inflammation. 2012;2012(1):271569. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253447/
4. Vastert SJ, Kuis W, Grom AA. Systemic JIA: new developments in the understanding of the pathophysiology and therapy. Best Practice & Research Clinical Rheumatology. 2009 Oct 1;23(5):655-64.
5. De Benedetti F, Schneider R. Systemic juvenile idiopathic arthritis. Textbook of pediatric rheumatology. 2016 Jan 1;7:205-16.
6. Grevich S, Shenoi S. Update on the management of systemic juvenile idiopathic arthritis and role of IL-1 and IL-6 inhibition. Adolescent health, medicine and therapeutics. 2017 Nov 9:125-35. https://www.dovepress.com/update-on-the-management-of-systemic- juvenile-idiopathic-arthritis-and-peer-reviewed-fulltext-article-AHMT
7. Garner AJ, Saatchi R, Ward O, Hawley DP. Juvenile idiopathic arthritis: a review of novel diagnostic and monitoring technologies. InHealthcare 2021 Dec 4 (Vol. 9, No. 12, p. 1683). MDPI. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700900/
8. Zaripova LN, Midgley A, Christmas SE, Beresford MW, Baildam EM, Oldershaw RA. Juvenile idiopathic arthritis: from aetiopathogenesis to therapeutic approaches. Pediatric Rheumatology. 2021 Aug 23;19(1):135. https://ped-rheum.biomedcentral.com/articles/ 10.1186/s12969-021-00629-8
9. Tjahjono L, Czaja R, Lalor L, Hasse-Rupp B, Wanat KA. Persistent papules and plaques in systemic juvenile idiopathic arthritis. Pediatric Dermatology. 2022 Jul;39(4):616-8. https:// pubmed.ncbi.nlm.nih.gov/35560434/
10. De Matteis A, Bindoli S, De Benedetti F, Carmona L, Fautrel B, Mitrovic S. Systemic juvenile idiopathic arthritis and adult-onset Still's disease are the same disease: evidence from systematic reviews and meta-analyses informing the 2023 EULAR/PReS recommendations for the diagnosis and management of Still's disease. Annals of the rheumatic diseases. 2024 Dec 1;83(12):1748-61. https://ard.bmj.com/content/83/12/1748
11. Ravelli A, Minoia F, Davì S, Horne A, Bovis F, Pistorio A, et al. . 2016 Classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: A european league against rheumatism/American college of rheumatology/ Paediatric rheumatology international trials organisation collaborative initiative. Arthritis Rheumatol. (2016) 68:566–76. doi: 10.1002/art.39332
12. DR SR, Balan S. Systemic juvenile idiopathic arthritis: the challenges and opportunities. Indian Journal of Rheumatology. 2024 Dec;19(4):303-1. https://journals.sagepub.com/doi/ 10.1177/ 09733698241256530
13. Poduval M, Bhaskar A. Juvenile Rheumatoid Arthritis [Internet]. https:// emedicine.medscape .com/article/1007276-overview
14. Saad N, Onel K. Overview of juvenile idiopathic arthritis. The Open Orthopaedics Journal. 2020 Sep 18;14(1):101-9
15. Hinze CH, Foell D, Kessel C. Treatment of systemic juvenile idiopathic arthritis. Nature Reviews Rheumatology. 2023 Dec;19(12):778-89. https://www.nature.com/articles/ s41584-023-01042-z

Most read articles by the same author(s)